Leung, Fay <br/><br/>
Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection?  [electronic resource] 

 -  Clinical orthopaedics and related research  Apr 2011 
 - 1009-15 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1528-1132 
<br/><br/><label>Standard No.: </label>10.1007/s11999-010-1725-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Arthroplasty, Replacement, Hip--adverse effects<br/>Bone Cements--therapeutic use<br/>British Columbia<br/>Chi-Square Distribution<br/>Female<br/>Hip Joint--microbiology<br/>Hip Prosthesis--adverse effects<br/>Humans<br/>Infection Control--methods<br/>Logistic Models<br/>Male<br/>Methicillin-Resistant Staphylococcus aureus--pathogenicity<br/>Middle Aged<br/>Patient Satisfaction<br/>Prosthesis Design<br/>Prosthesis-Related Infections--microbiology<br/>Quality of Life<br/>Range of Motion, Articular<br/>Recovery of Function<br/>Recurrence<br/>Reoperation<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Staphylococcus epidermidis--pathogenicity<br/>Surveys and Questionnaires<br/>Time Factors<br/>Treatment Outcome